← Eichor
Condition: Biotherapies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Biotherapies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06305299Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT06347068Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06530303Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy
NA · 2 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT06856044STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL C
NA · 17 location(s) · University Hospital, Clermont-Ferrand · NCT04973423Medical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
NA · 9 location(s) · Francisco J. Blanco · NCT07678112High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT04331639Impact of the Therapeutic Education Program "living with a Chronic Inflammatory Disease Under Biotherapy" on Patient Com
Phase N/A · 1 location(s) · Groupe Hospitalier de Bretagne Sud · NCT06620770Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
NA · 6 location(s) · University of Glasgow · NCT07522528TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06538012Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Phase 2 · 1 location(s) · Medical University of Lodz · NCT06453317Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT03915262Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
NA · 1 location(s) · Marmara University · NCT07491913TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06640582Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
Phase 4 · 28 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT05169593TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06532799CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial
EARLY_Phase 1 · 1 location(s) · Institute of Hematology and Blood Transfusion, Czech Republi · NCT06765876MRE Predictors of Disease Relapse After Stopping Biologics
Phase N/A · 1 location(s) · University College, London · NCT06124287Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
Phase N/A · 1 location(s) · University of British Columbia · NCT06453720A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcera
Phase N/A · 1 location(s) · Janssen Scientific Affairs, LLC · NCT04372108Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Phase N/A · 10 location(s) · Medical University Innsbruck · NCT06954311Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · 85 location(s) · AbbVie · NCT06332534Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy
NA · 1 location(s) · Hôpital Européen Marseille · NCT04899154MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07470502Evaluation of Skin Tests in Biotherapy Allergies
NA · 1 location(s) · University Hospital, Angers · NCT06971848Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
Phase N/A · 3 location(s) · Jonathan Krygier · NCT07234838TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT06532812Safety and Tolerability of AI-Designed Pan-Cancer Neoantigen mRNA Vaccine (PAN-NeoVax) in Advanced Solid Tumors
Phase 1 · 2 location(s) · West China Hospital · NCT07560943Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Phase 3 · 41 location(s) · SWOG Cancer Research Network · NCT07383441Downstream Effects of Airway Mucus Plugs on 129Xenon MRI in Severe Asthma
Phase N/A · 1 location(s) · Bastiaan Driehuys · NCT07139899
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.